Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association

MJ Feinstein, PY Hsue, LA Benjamin, GS Bloomfield… - Circulation, 2019 - Am Heart Assoc
As early and effective antiretroviral therapy has become more widespread, HIV has
transitioned from a progressive, fatal disease to a chronic, manageable disease marked by …

The challenge of HIV treatment in an era of polypharmacy

D Back, C Marzolini - Journal of the International AIDS Society, 2020 - Wiley Online Library
Introduction The availability of potent antiretroviral therapy has transformed HIV infection into
a chronic disease such that people living with HIV (PLWH) have a near normal life …

Patterns of cardiovascular mortality for HIV-infected adults in the United States: 1999 to 2013

MJ Feinstein, E Bahiru, C Achenbach… - The American journal of …, 2016 - Elsevier
With widespread availability and the use of antiretroviral therapy, patients with human
immunodeficiency virus (HIV) in the United States are living long enough to experience non …

HIV infection and coronary heart disease: mechanisms and management

PY Hsue, DD Waters - Nature Reviews Cardiology, 2019 - nature.com
Antiretroviral therapy has largely transformed HIV infection into a chronic disease condition.
As such, physicians and other providers caring for individuals living with HIV infection need …

HIV and cardiovascular disease

K So-Armah, LA Benjamin, GS Bloomfield… - The lancet HIV, 2020 - thelancet.com
HIV-related cardiovascular disease research is predominantly from Europe and North
America. Of the estimated 37· 9 million people living with HIV worldwide, 25· 6 million live in …

Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors

DR Bakal, LE Coelho, PM Luz, JL Clark… - Journal of …, 2018 - academic.oup.com
Background Obesity rates are increasing among HIV-infected individuals, but risk factors for
obesity development on ART remain unclear. Objectives In a cohort of HIV-infected adults in …

Inflammation, immune activation, and cardiovascular disease in HIV

E Nou, J Lo, SK Grinspoon - Aids, 2016 - journals.lww.com
Cardiovascular disease is one of the leading causes of morbidity and mortality in people
living with HIV. Several epidemiological studies have shown an increased risk of myocardial …

HIV and ischemic heart disease

A Vachiat, K McCutcheon, N Tsabedze… - Journal of the American …, 2017 - jacc.org
The association of coronary heart disease (CHD) and human immunodeficiency virus (HIV)
infection has been well recognized for many years. The etiology of the increased prevalence …

[HTML][HTML] The epidemiology, mechanisms, diagnosis and treatment of cardiovascular disease in adult patients with HIV

RJ Henning, JN Greene - American journal of cardiovascular …, 2023 - ncbi.nlm.nih.gov
More than 1.2 million people in the United States have Human Immunodeficiency Virus
(HIV) infections but 13% of these people are unaware of their HIV infection. Current …

Assessment and management of cardiovascular risk factors among US veterans with prostate cancer

L Sun, RB Parikh, RA Hubbard, J Cashy… - JAMA network …, 2021 - jamanetwork.com
Importance Cardiovascular disease is a leading cause of mortality in patients with prostate
cancer, and androgen deprivation therapy (ADT) may worsen cardiovascular risk …